DJIA 18,285.74 0.00 0.00%
NASDAQ 5,090.79 0.00 0.00%
S&P 500 2,130.82 0.00 0.00%
market minute promo

Express Scripts (NASDAQ: ESRX)



company name or ticker
Company Photos
(Click to zoom)

Double-Digit Spike in Drug Costs Prescribes Profits for PBMs

A new report by employee benefit consultancy Aon Hewitt forecasts a 10% increase in employer drug costs through 2017, which puts a spotlight on pharmacy benefit management companies to assist employers, health plans, and government insurers such as Medicare and Medicaid to control prescription spending.

What Could Possibly Go Wrong With Gilead Sciences Inc. Stock?

Three risks for Gilead Sciences.

AbbVie's HCV Treatment Granted Priority Review in Japan - Analyst Blog

The Best Stock to Invest in Hep C

In the multibillion-dollar market for hepatitis C, this company stands above the crowd.

Analyzing Chris Davis' Top Holdings

Stock of the Week: UnitedHealth Group Inc. (UNH)

The Long Strange Trip Of Walgreens And Express Scripts

A New Drug Could Halt Weight Gain in Patients Taking These Antipsychotics

Alkermes Plc's ALKS 3831 could help patients that take atypical antidepressants avoid gaining weight.

Express Scripts Vs. CVS: Who Wins?

Don't Play On Takeover Rumors - Cramer's Mad Money (4/9/15)

See More Articles...